Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 3, 2003, Pages 365-370

  Martín Mazuelos, Estrella ^a   Pemán, Javier ^b   Valverde, Anastasio ^a   Chaves, Mónica ^a   Serrano, M Carmen ^a   Cantón, Emilia ^b  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Aspergillus spp.; MIC; Sensititre YeastOne; Susceptibility testing

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVIPES; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS GLAUCUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; COLORIMETRY; CONTROLLED STUDY; DILUTION; EUROTIALES; FUNGUS ISOLATION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRAIN DIFFERENCE; YEAST;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; COLORIMETRY; DRUG RESISTANCE, FUNGAL; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; REPRODUCIBILITY OF RESULTS;

EID: 0141741223     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg384     Document Type: Article

References (23)

1. Denning, D. W., Venkateswarlu, K., Oakley, K. L. et al. (1997). Itraconazole resistance in Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy 41, 1364-8.
2. Denning, D. W., Radford, S. A., Oakley, K. L. et al. (1997). Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. Journal of Antimicrobial Chemotherapy 44, 401-14.
3. Oakley, K. L., Morrisey, G. & Denning, D. W. (1997). Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy 41, 1504-7.
4. Verweij, P. E., Te Dorsthorst, D. T. A., Rijs, A. J. M. M. et al. (2002). Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998. Journal of Clinical Microbiology 40, 2648-50.
5. Sutton, D. A., Sanche, S. E., Revankar, G. S. et al. (1999). In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. Journal of Clinical Microbiology 37, 2343-5.
6. Iwen, P. C., Rupp, M. E., Langnas, A. N. et al. (1998). Invasive pulmonary aspergillosis due to Aspergillus terreus: 12 years experience and review of the literature. Clinical Infectious Diseases 26, 1092-7.
7. National Committee for Clinical Laboratory Standards. (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-Forming Filamentous Fungi: Approved Standard M38-A. NCCLS, Wayne, PA, USA.
8. Espinel-Ingroff, A., Pfaller, M., Messer, S. A. et al. (1999). Multicenter comparison of the sensititre YeastOne colorimetric antifungal panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeast and yeast-like organisms. Journal of Clinical Microbiology 37, 591-5.
9. Pfaller, M. A., Messer, S. A., Karlson, A. et al. (1998). Evaluation of Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media. Journal of Clinical Microbiology 36, 2586-9.
10. Martín-Mazuelos, E., Gutiérrez, M. J., Aller, A. I. et al. (1999). A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp. Journal of Antimicrobial Chemotherapy 43, 477-81.
11. Sanchez-Sousa, A., Alvarez, M. E., Maiz, L. et al. (1999). Aspergillus fumigatus susceptibility testing by colorimetric microdilution. Journal de Mycologie Médicale 9, 103-6.
12. Meletiadis, J., Mouton, J. W., Meis, J. F. G. M. et al. (2002). Comparison of the Etest and sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species Journal of Clinical Microbiology 40, 2876-85.
13. Szekely, A., Johnson, E. M. & Warnock, D. W. (1999). Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of moulds. Journal of Clinical Microbiology 37, 1480-3.
14. Pfaller, M. A., Messer, S. A., Mills, K. et al. (2000). In vitro susceptibility testing of filamentous fungi: Comparison of Etest and reference microdilution methods for determining itraconazole MICs. Journal of Clinical Microbiology 38, 3359-61.
15. Espinel-Ingroff, A. (2001). Comparison of the E-test with the NCCLS M38-A method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. Journal of Clinical Microbiology 39, 1360-7.
16. Larone, D. H. (1995). Medically Important Fungi: A Guide to Identification, 3rd edn. ASM Press, Washington, DC, USA.
17. de Hoog, G. S., Guarro, J., Gené, J. et al. (2000). Atlas of Clinical Fungi, 2nd edn. ASM Press, Washington, DC, USA.
18. Barry, A. L., Pfaller, M. A., Brown, S. D. et al. (2000). Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. Journal of Clinical Microbiology 38, 3457-9.
19. Espinel-Ingroff, A. (1998). Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeast. Journal of Clinical Microbiology 36, 2950-6.
20. Oakley, K. L., Moore, C. B. & Denning, D. W. (1999). Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipids complex, and itraconazole. Antimicrobial Agents and Chemotherapy 43, 1264-6.
21. Espinel-Ingroff, A., Bartlett, M., Chaturvedi, V. et al. (2001). Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus, spp.: NCCLS collaborative evaluation. Antimicrobial Agents and Chemotherapy 45, 1828-35.
22. Lozano-Chiu, M., Paetznick, V. L., Ghannoum, M. A. et al. (1998). Detection of resistance to amphotericin B among Cryptococcus neotormans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. Journal of Clinical Microbiology 36, 2817-22.
23. Wanger, A., Mills, K., Nelson, P. W. et al. (1995). Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrobial Agents and Chemotherapy 39, 2520-2.